Adult-onset neuronal ceroid lipofuscinosis misdiagnosed as autoimmune encephalitis and normal-pressure hydrocephalus: A 10-year case report and case-based review
Huasheng Huang,Yuqi Liao,Yanni Yu,HuiHui Qin,Yi Zhi Wei,Liming Cao
DOI: https://doi.org/10.1097/md.0000000000040248
IF: 1.6
2024-10-30
Medicine
Abstract:Neuronal ceroid lipofuscinosis (NCL) is a group of rare, fatal, inherited neurodegenerative lysosomal storage disorders. [ 1 ] NCL exhibits a high degree of genetic and clinical heterogeneity, with characteristic pathological changes, including intraneuronal wax-like or lipofuscin-like deposits of autoimmune fluorescent substances. [ 2 , 3 ] The prevalence of NCL is approximately 1 in 12,500 in Europe and North America, [ 4 ] with an estimated global incidence of 1 in 100,000. [ 5 ] Common symptoms of NCL include progressive vision loss, mental and motor deterioration, epileptic seizures, and dementia. [ 1 , 2 ] Based on the age of onset and clinical features, NCL is classified as congenital, infantile, late infantile, juvenile, or adult-onset NCL (ANCL). [ 1 ] ANCL, also known as Kufs disease, is a rare form of NCL that has an onset in adulthood. Two clinical Kufs phenotypes have been described: 1 featuring generalized tonic-clonic seizures and the other characterized by dementia. [ 6 ] NCL generally begins in childhood, with an earlier onset associated with a more severe clinical course and prognosis. Early diagnosis is crucial to initiate therapy in asymptomatic patients. However, the early diagnosis of NCL is challenging.
medicine, general & internal